TCT 2023 Late-Breaking Science Collection

Published: 09 January 2024

  • Views:

    Views Icon 315

  • Likes:

    Heart Icon 7
Average (ratings)
No ratings
Your rating

Overview

Stay up-to-date with our regular review series, View from the Thoraxcenter hosted by Prof Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcenter, Erasmus MC, Rotterdam, NL). In this #TCT2023 edition they provide a short analysis of the most pertinent data from the late-breaking science presentations. 

Short, accessible Expert Interviews were conducted with investigators focusing on study design, key results and applicability of the latest data. 

More from this programme

Part 1

View from the Thoraxcenter

2 sessions
View from the Thoraxcenter: TCT 23 Late-breaking Science Preview Watch now
View from the Thoraxcenter: TCT 23 Late-breaking Science Wrap Up Watch now

Part 2

Highlights

3 sessions
5 Trials That Will Change My Practice With Dr Kendra Grubb Watch now
5 Trials That Will Change My Practice With Dr Mirvat Alasnag Watch now
5 Trials That Will Change My Practice With Dr Bernardo Cortese Watch now

Part 3

Interviews

6 sessions
5Y Outcomes From the PARTNER 3 Low-Risk Trial Watch now
AGENT IDE: AGENT Paclitaxel Coated Balloon Angioplasty for In-Stent Restenosis Watch now
Four-Year Outcomes from the EVOLUT Low Risk Trial Watch now
PICSO-AMI-I: Pressure Controlled Intermittent Coronary Sinus Occlusion in Acute Myocardial Infarction Watch now
WATCH-TAVR: WATCHMAN for Patients with AF Undergoing TAVR Watch now
IFR SWEDEHEART: iFR Vs FFR Guided Coronary Revascularisation Long-Term Clinical Outcomes Watch now

About the episode

TCT 23 - We are joined by Dr Mirvat Alasnag (The King Fahd Armed Forces Hospital, SA) for an insightful summary of the late-breaking trials that are expected to have an impact on interventional science and clinical practice.

 

Trials covered in detail include:


Agent IDE
ALIGN-AR
PARTNER 3
EVOLUT Low-Risk
TRISCEND

 

Recorded remotely from Jeddah, 2023.

Editor: Jordan Rance
Video Specialist: Dan Brent

Faculty Biographies

Mirvat Alasnag

Mirvat Alasnag

Director of Catheterization Laboratory

Dr Mirvat Alasnag is an editorial board member of Interventional Cardiology: Reviews, Research, Resources (ICR3), joining the board in October 2020 and is also on the editorial board for US Cardiology Review (USC).

Dr Mirvat Alasnag is the Director of the Catheterization Laboratory at the King Fahad Armed Forces Hospital in Jeddah, Saudi Arabia. She was the first female interventional cardiologist in the Gulf region and has since represented women on multiple medical committees, including the Saudi Arabian Cardiac Interventional Society Board & the EAPCI Women’s Steering Committee. She is the current ACCWIC International Working Group Chair and an SCAI WIN member.

Dr Alasnag trained in Clinical Cardiology and Interventional Cardiology at Loma Linda University Medical Center (Loma Linda, California) and Harper University Hospital, Detroit Medical Center (Detroit, Michigan), respectively. Since her graduation in 2009 to date, she has been…

View full profile

Comments

You must be to comment. If you are not registered, you can register here.